Pacific Biosciences of California Inc (STU:P09)
€ 1.4505 -0.0070 (-0.48%) Market Cap: 458.21 Mil Enterprise Value: 833.54 Mil PE Ratio: 0 PB Ratio: 209.38 GF Score: 57/100

Q4 2025 Pacific Biosciences of California Inc Earnings Call Transcript

Feb 12, 2026 / 10:00 PM GMT
Release Date Price: €1.54 (+0.48%)

Key Points

Positve
  • Pacific Biosciences of California Inc (PACB) reported a 14% year-over-year revenue growth in Q4 2025, reaching $44.6 million.
  • Consumable revenue reached record levels, with a 15% year-over-year increase, driven by strong demand in clinical sequencing applications.
  • The company achieved a significant improvement in non-GAAP gross margin, increasing from 31% in Q4 2024 to 40% in Q4 2025.
  • The launch of the SparkNex chemistry is expected to lower the price per genome, potentially increasing system utilization and expanding market share.
  • PACB successfully reduced non-GAAP operating expenses by 18% year-over-year, contributing to a lower cash burn and improved financial profile.
Negative
  • Instrument revenue decreased by 18% for the full year 2025, primarily due to lower Revio shipments.
  • The academic funding environment remains challenging, impacting instrument sales and creating uncertainty for future growth.
  • Despite strong growth in consumables, the overall revenue growth for 2025 was only 4%, indicating potential headwinds in other areas.
  • The company anticipates continued volatility in component costs, such as memory, which could impact gross margins.
  • PACB's cash and investments decreased from $389.9 million at the end of 2024 to $279.5 million at the end of 2025, reflecting ongoing financial pressures.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PACB.OQ - Pacific Biosciences of California Inc
Q4 2025 Pacific Biosciences of California Inc Earnings Call
Feb 12, 2026 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to PackBuyo's quarter and full year 2025 earnings Salford's call.

All participants will be in listen-only mode.

Should you need assistance, please signal a conference specialist by pressing the star key followed by 0.

After today's presentation, there will be an opportunity to ask questions

To ask a question, you may press star than one on your telephone keypad and to a driver question, please press star in 2.

Please note that today's event is being recorded.

I would now like to turn the conference over to Kelly Gerra with investor relations.

Please go ahead.

Good afternoon and welcome to Tabi's 4th
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot